By targeting MALDI-ToF mass spectral detection to viral envelope glycoproteins, a multidisciplinary team approach has achieved a multifaceted clinically MALDI ToF MS screening test for COVID-19 and future such pandemics that may arise. This evidence concerns the gene ERVW-1 and COVID-19.